United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift Medical's Patent
MolecuLight Victorious in its Efforts to Prove Swift Medical Did Not Merit a Patent
Stay updated with breaking news from Ralph Dacosta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MolecuLight Victorious in its Efforts to Prove Swift Medical Did Not Merit a Patent
(0) TORONTO, May 7, 2021 /PRNewswire/ -- photonamic GmbH & Co. KG (Head office: Pinneberg, Germany; CEO: Ulrich Kosciessa, Ph.D.) ("photonamic"), a subsidiary of SBI Holdings, Inc. (Head office: Minato-ku, Tokyo; Representative Director, President and CEO: Yoshitaka Kitao) the leader in the pharmaceutical development, translation and global commercialization of 5-aminolevulinic acid ("5-ALA") (*) today announces that its Canadian subsidiary SBI ALApharma Canada Inc. (Head office: Toronto, Canada; CEO & CTO, Dr. Ralph DaCosta) ("SBI Canada") has enrolled the first patient in its Pivotal Phase...